CN Patent

CN115227661B — 一种利格列汀片及其制备方法

Assigned to Jilin Huisheng Biopharmaceutical Co ltd · Expires 2022-12-13 · 3y expired

What this patent protects

本发明涉及一种利格列汀片及其制备方法，本发明提供的制备方法选择将利格列汀和特定辅料制备得到内颗粒，再将内颗粒进一步与部分辅料制备成药物颗粒，最后外加硬脂酸镁混合、压片和包衣得到所述利格列汀片。利用本发明提供的制备方法得到的利格列汀片具有较好的溶出行为，并且具有优异的稳定性。

USPTO Abstract

本发明涉及一种利格列汀片及其制备方法，本发明提供的制备方法选择将利格列汀和特定辅料制备得到内颗粒，再将内颗粒进一步与部分辅料制备成药物颗粒，最后外加硬脂酸镁混合、压片和包衣得到所述利格列汀片。利用本发明提供的制备方法得到的利格列汀片具有较好的溶出行为，并且具有优异的稳定性。

Drugs covered by this patent

Patent Metadata

Patent number
CN115227661B
Jurisdiction
CN
Classification
—
Expires
2022-12-13
Drug substance claim
No
Drug product claim
No
Assignee
Jilin Huisheng Biopharmaceutical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.